FDA.reportPublic FDA data

tazarotene 0.05 % Topical Gel

RxCUI
313199
RxNorm name
tazarotene 0.05 % Topical Gel
Display name
tazarotene 0.05 % Topical Gel
Full name
tazarotene 0.05 % Topical Gel
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TazoracTAZAROTENEAlmirall, LLC4e4e4b81-420e-4492-8a74-80b692a800572025-11-13Warnings, Adverse reactionsExact identifier
rxcui: 313199
TazaroteneTAZAROTENESolaris Pharma Corporationf1c98c4a-f101-4f3c-851a-39c827415c462025-01-02Warnings, Adverse reactionsExact identifier
rxcui: 313199
TAZAROTENETAZAROTENEPadagis Israel Pharmaceuticals Ltdffd11dee-4266-4201-9573-1e82c2d30a632024-01-01Warnings, Adverse reactionsExact identifier
rxcui: 313199
TAZAROTENETAZAROTENECosette Pharmaceuticals, Inc.ecd718fd-c06e-4b3a-8aca-fa51e7c51a662023-11-29Warnings, Adverse reactionsExact identifier
rxcui: 313199

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4e4e4b81-420e-4492-8a74-80b692a80057tazarotene 0.05 % Topical Gel [PSN] · tazarotene 0.0005 MG/MG Topical Gel [SCD] · tazarotene 0.05 % Topical Gel [SY]34These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 199720251113
f1c98c4a-f101-4f3c-851a-39c827415c46tazarotene 0.05 % Topical Gel [PSN] · tazarotene 0.0005 MG/MG Topical Gel [SCD] · tazarotene 0.05 % Topical Gel [SY]34These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 199720250102
ffd11dee-4266-4201-9573-1e82c2d30a63tazarotene 0.05 % Topical Gel [PSN] · tazarotene 0.0005 MG/MG Topical Gel [SCD] · tazarotene 0.05 % Topical Gel [SY]33These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 199720240101
ecd718fd-c06e-4b3a-8aca-fa51e7c51a66tazarotene 0.05 % Topical Gel [PSN] · tazarotene 0.0005 MG/MG Topical Gel [SCD] · tazarotene 0.05 % Topical Gel [SY]32These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05%, for topical use Initial U.S. Approval: 199720231129